Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HER2 Vaccine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
A variety of ERBB2 (HER2) vaccines are under development and are designed to stimulate active immunity against tumor cells overexpressing ERBB2 (HER2) (PMID: 23585514). |
| DrugClasses | HER2 (ERBB2) Vaccine 15 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| HER2 Vaccine | HER2 Vaccine | 0 | 3 |
| HER2 Vaccine + Lenvatinib + Nogapendekin alfa inbakicept + Pembrolizumab | HER2 Vaccine Lenvatinib Nogapendekin alfa inbakicept Pembrolizumab | 0 | 1 |
| HER2 Vaccine + Lenvatinib + Pembrolizumab | HER2 Vaccine Lenvatinib Pembrolizumab | 0 | 1 |